Therefore, in this study, we evaluated the correlation between clinical data suggesting cachexia in patients with Esophageal Cancer (EC) and plasma GDF15 to assess the usefulness of GDF15 as a potential biomarker for cachexia and risk factors for postoperative complications. This evidence concerns the gene GDF15 and Cachexia.